Senior insider sale
SVP, GC & Corporate Secretary at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$3.30M
94.88K shares
REED ELIZABETH E plans to sell 94.88K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $3.30M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Performance Restricted Stock Unit Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2026 | Performance Restricted Stock Unit Vesting Compensation | 7.21K | — |
| Total | 7.21K | ||
Completed
Units to sell
37.50K
Market value
$1.54M
Units to sell
10K
Market value
$300.0K
Units to sell
10K
Market value
$280.9K
Units to sell
10K
Market value
$278.3K
Units to sell
2.99K
Market value
$96.4K
Units to sell
7.17K
Market value
$230.5K
Units to sell
10K
Market value
$273.4K
Planned — Approximate Date
Units to sell
7.21K
Market value
$302.5K
Units
94.88K
Value
$3.30M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 37.50K | $1.54M | — | Completed |
4/1/2026 | 10K | $300.0K | — | Completed |
3/16/2026 | 10K | $280.9K | — | Completed |
2/17/2026 | 10K | $278.3K | — | Completed |
2/4/2026 | 2.99K | $96.4K | — | Completed |
2/3/2026 | 7.17K | $230.5K | — | Completed |
1/20/2026 | 10K | $273.4K | — | Completed |
| Planned — Approximate Date | ||||
4/14/2026 | 7.21K | $302.5K | NASDAQ | Planned |
| Total | 94.88K | $3.30M | ||